NCT05212337View on ClinicalTrials.gov

FITMI - First In Treating Male Infertility

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 22, 2024

Study Completion Date

September 30, 2025

Conditions
Infertility, Male
Interventions
DRUG

Denosumab

Subcutaneous injection with 60 mg Denosumab once

DRUG

Sodium chloride

Subcutaneous injection with NaCl once

Trial Locations (1)

Unknown

Department of Growth and Reproduction, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Martin Blomberg Jensen

OTHER